Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)
China flag China · Delayed Price · Currency is CNY
28.90
-0.52 (-1.77%)
Jun 17, 2025, 2:45 PM CST

Guangzhou LBP Medicine Science & Technology Company Description

Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China.

The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase chain reaction products, such as human papillomavirus gene test kits, sample preservation solutions, and automatic nucleic acid molecular hybridization instruments; fluorescence in situ hybridization products comprising auto-fish instruments, and AML1/ETO, EGFR, BCR/ABL fusion, PML/RARA, and TOP2A gene testing kits; and digital pathology products pathological medical image analysis processing systems, real-time microscopic visual field sharing systems, and bingli scanner.

It also provides immunohistochemistry products including automatic antigen repair instrument and automatic immunocytochemical staining machine, as well as conversional pathology equipment.

The company was founded in 2005 and is based in Guangzhou, China.

Guangzhou LBP Medicine Science & Technology Co., Ltd.
Country China
Founded 2005
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 796
CEO Xiangting Cai

Contact Details

Address:
No. 2, Kexin Street
Guangzhou, 510663
China
Phone 86 20 3229 9997
Website gzlbp.com

Stock Details

Ticker Symbol 688393
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE1000043R4
SIC Code 3845

Key Executives

Name Position
Xiangting Cai Chairman of the Board and GM
Zhefeng Deng Deputy GM and Director
Zongsheng Liang Deputy GM and Director
Quanneng Hou Chief Financial Officer and Board Secretary
Aiping Huang Accounting Supervisor